In this episode, we dive into the groundbreaking research by Dr. Richard Bartlett and Jon Fleetwood on budesonide, an inhaled corticosteroid, and its potential role as both an early and late-stage treatment for COVID-19. Drawing from a comprehensive review of global studies—including the U.K. STOIC and PRINCIPLE trials, the Brazil TOGETHER trial, and research from Saudi Arabia, Australia, and India—we explore the evidence supporting budesonide’s effectiveness in reducing disease severity and improving recovery times. With endorsements from major health organizations and its inclusion in the WHO’s essential medicines list, could budesonide be a game-changer in the fight against COVID-19? Tune in as we break it all down.

Read and download the full article here: https://www.thegms.co/publichealth/pubheal-rw-24090601.pdf

🎧 Listen now to learn more about this promising treatment and its implications for global healthcare.